Marinus Pharma’s Epilepsy Drug Shows Promise; SanaCurrents Closing Out Coverage
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) disclosed results of its phase II [...]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) disclosed results of its phase II [...]
$KRON Probability Sentiment SUMMARY The [...]
Biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Probability Sentiment [...]
$PLRX Probability Sentiment SUMMARY Idiopathic [...]
Anaptysbio, Inc. (NASDAQ:ANAB) Probability Sentiment [...]
As of mid-day trading on January 22, Aurinia Pharmaceuticals Inc [...]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Probability Sentiment [...]
$IMVT Probability Sentiment SUMMARY Since [...]